Showing 419 results

Filters Content type: News, Editors' picks, About HIV Topic: Changing treatment

A change of HIV treatment may be necessary because of side-effects, the development of drug resistance, treatment not being fully effective or because of interactions between HIV drugs and other medications.

Changing treatment

Raltegravir-resistant HIV stays susceptible to dolutegravir in lab

Editor's pick
International AIDS Society
13 November 2012
Treatment interruptions

Pegylated interferon may maintain HIV suppression and reduce viral DNA integration

Editor's pick
HIVandHepatitis.com
12 November 2012
New & experimental HIV treatments

Is protease inhibitor monotherapy sufficient to keep HIV under control in the brain?

Editor's pick
CATIE
2 November 2012
Generic medicines

The generic generation

News
22 October 2012
People with limited treatment options

Booster HIV Drug Can Be Dropped

Editor's pick
MedPage Today
13 September 2012
Diabetes

Glucose metabolism worsens in HIV treatment-experienced taking NRTI-sparing regimens

News
24 August 2012
Changing treatment

Are antiretroviral switch or simplification studies of benefit for patients?

News
15 August 2012
Finance & funding

First generic HIV drugs could save US at least $920 million a year

News
27 July 2012
Changing treatment

Second-line HIV therapy effective and durable in South Africa, and adherence support could improve rates of viral suppression

News
27 June 2012
Changing treatment

Big delays in switching to second-line ART in South Africa

News
8 June 2012
Changing treatment

Treatment switches becoming less common, side-effects still the key reason for switching

News
24 April 2012
HIV treatment for children & young people

FDA Approves INTELENCE® (etravirine) Tablets for Treatment-Experienced Pediatric Patients with HIV-1

Editor's pick
Janssen press release
28 March 2012
Health monitoring in resource-limited settings

When does viral load testing add value in sub-Saharan Africa?

News
8 March 2012
Treatment outcomes & life expectancy

Second-line treatment failure most often due to poor adherence in low and middle-income countries

News
24 February 2012
Health monitoring in resource-limited settings

Treatment switches after CD4 count decline reduce risk of death by 75% in Zambia, Malawi

News
9 December 2011
New & experimental HIV treatments

Switching from efavirenz to rilpivirine single tablet is safe and effective

News
18 October 2011
Changing treatment

Switching to once-daily etravirine a safe and effective option for individuals taking suppressive protease inhibitor therapy

News
20 September 2011
Changing treatment

A fifth of patients discontinue Atripla within a year, CNS side-effects the main reason

News
19 September 2011
Health monitoring in resource-limited settings

Viral load monitoring of ART patients linked to lower death rate on treatment in southern Africa

News
14 July 2011
Changing treatment

Confirmatory viral load reduces HIV treatment switches fourfold in 6-country African study

News
6 July 2011
Pharmaceutical industry

Gilead inks one combo HIV drug pact as it explores new ties with J&J -

Editor's pick
FierceBiotech
28 June 2011
Side effects

Switch from efavirenz to raltegravir improves mood and lipid profiles

News
7 June 2011
Changing treatment

Emcure Pharmaceuticals donates second line AIDS drugs to NACA

Editor's pick
Moreover.com HIV/AIDS feed
19 May 2011
Changing treatment

International team to investigate second-line HIV therapy in Africa

Editor's pick
University College Dublin
18 May 2011